Genes2Me launches RT PCR test kit for monkeypox

New Delhi: Genes2Me Pvt. Ltd., IVD manufacturers, announced the development of the Real-Time PCR-based kit for quick detection of monkeypox virus with a fast turnaround result time of less than 50 minutes.

The diagnostic company informed that the kit is available in both the standard version for any commonly available Real Time PCR instruments as well as Point-of-Care format on Genes2Me Rapi-Q HT Rapid RT-PCR device. The Point-of-Care solution can be used for screening at multiple sites including hospitals, airports, diagnostic labs, health camps, etc.

After more than 16,000 cases being reported from 75 countries and territories, World Health Organisation (WHO) has declared the rapidly spreading monkeypox outbreak a Public Health Emergency of International Concern (PHEIC). Scientists from Genes2Me have been able to develop “POX-Q Multiplexed RT-PCR kit” for the detection of monkeypox virus along with differentiation from Varicella Zoster Virus (Chicken Pox) in a single tube multiplex reaction format. The first of its kind Made in India kit is available as Research-Use only (RUO) and based on Gold standard taqman chemistry based RT PCR method.

Commenting on the development of the RTPCR kit for monkeypox, Neeraj Gupta, CEO and Founder, Genes2Me said, “Understanding the value of time, we have launched this kit which will give the result in less than 50 minutes with the highest accuracy. We have the current capacity to manufacture five million test kits in a week, however, it can be scaled up to two million tests in a day with the added demand.”